McKesson Corporation $MCK Shares Bought by Cibc World Market Inc.

Cibc World Market Inc. raised its holdings in shares of McKesson Corporation (NYSE:MCK) by 28.1% in the third quarter, Holdings Channel.com reports. The firm owned 24,243 shares of the company’s stock after buying an additional 5,318 shares during the period. Cibc World Market Inc.’s holdings in McKesson were worth $18,729,000 as of its most recent SEC filing.

A number of other institutional investors also recently made changes to their positions in MCK. IAM Advisory LLC increased its stake in shares of McKesson by 0.3% in the third quarter. IAM Advisory LLC now owns 3,908 shares of the company’s stock worth $3,019,000 after buying an additional 13 shares during the last quarter. PDS Planning Inc increased its position in shares of McKesson by 1.1% in the 3rd quarter. PDS Planning Inc now owns 1,209 shares of the company’s stock worth $934,000 after purchasing an additional 13 shares during the last quarter. Cardinal Point Capital Management ULC raised its stake in shares of McKesson by 2.2% in the 2nd quarter. Cardinal Point Capital Management ULC now owns 645 shares of the company’s stock valued at $473,000 after purchasing an additional 14 shares in the last quarter. Goldstein Advisors LLC lifted its position in shares of McKesson by 4.4% during the third quarter. Goldstein Advisors LLC now owns 334 shares of the company’s stock worth $258,000 after purchasing an additional 14 shares during the last quarter. Finally, Warren Street Wealth Advisors LLC grew its stake in McKesson by 4.9% in the third quarter. Warren Street Wealth Advisors LLC now owns 319 shares of the company’s stock worth $246,000 after purchasing an additional 15 shares in the last quarter. 85.07% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

MCK has been the topic of a number of research analyst reports. Barclays started coverage on McKesson in a report on Monday, December 8th. They set an “overweight” rating and a $960.00 target price on the stock. Wall Street Zen cut McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Wells Fargo & Company lifted their price objective on shares of McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a report on Thursday, February 5th. Weiss Ratings cut shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Finally, JPMorgan Chase & Co. lifted their price target on shares of McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, McKesson currently has a consensus rating of “Moderate Buy” and a consensus price target of $937.07.

Insider Activity at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the company’s stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the transaction, the executive vice president owned 2,268 shares in the company, valued at $1,851,096.24. This represents a 10.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.08% of the company’s stock.

McKesson Trading Down 3.9%

McKesson stock opened at $916.08 on Friday. The company’s 50-day moving average price is $837.61 and its two-hundred day moving average price is $785.95. The stock has a market cap of $112.21 billion, a price-to-earnings ratio of 26.35, a PEG ratio of 1.53 and a beta of 0.40. McKesson Corporation has a 52 week low of $585.22 and a 52 week high of $971.93.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The firm had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s quarterly revenue was up 11.4% on a year-over-year basis. During the same period last year, the company posted $8.03 EPS. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Research analysts expect that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.